Close
UCL in the media
Lifschutz Davidson Sandilands reveals UCL masterplan
UCL has set out an ambitious programme of investment in its central London estate after an intensive planning and consultation process led by UCL's Estates division and architecture practice Lifschutz Davidson Sandilands.
Read: Architects' Journal (£) Building Design (£) More: UCL news storyThe good life
Professor Mika Kivimaki (UCL Epidemiology & Public Health) and Dr David Gems (UCL Institute of Healthy Ageing) explain trends in heart disease in the UK and Finland.
Read: GuardianAffairs of the heart: the triumph of drugs
Dr Kevin Fong (UCL Neuroscience, Physiology & Pharmacology) talks to his former tutor, Prof Raymond MacAllister of University College Hospital, about drugs that reduce the number of heart attacks.
Watch: GuardianLondon's 1000 most influential people 2011: Education
The Evening Standard newspaper names UCL Provost Professor Malcolm Grant as one of London's most influencial people in the education sector.
Read: Evening StandardScience is Vital award-winner refocuses campaign on careers
Dr Jennifer Rohn (UCL Laboratory for Molecular Cell Biology) has won Research Fortnight's Achiever of the Year award for her work on the Science is Vital campaign.
Read: Research Fortnight (£)THE Scholarly Web
Dr Melissa Terras (UCL Digital Humanities) is measuring the impact of making her research open access by adding one paper a week to UCL Discovery and then blogging and tweeting about it.
Read: Times Higher EducationWilliam Turnbull: Too good to be forgotten
A short biography of William Turnbull, an alumnus of the UCL Slade School of Fine Art, who is described as the "greatest unsung - or forgotten - hero of the British sculptural scene".
Read: IndependentChildren with high IQs more likely to use drugs as adults
A cohort study by Dr David Batty (UCL Epidemiology & Public Health) and academics from Cardiff University has found that children with high IQs are more likely to use illegal drugs as teenagers and adults.
Read: LA TimesGeron abandons stem cell therapy as treatment for paralysis
Professor John Martin (UCL Cardiovascular Medicine) comments on the announcement by biotech company Geron that it will abandon the first ever stem cell trial to treat paralysis.
Read: Guardian More: FT New Scientist BBC News OnlineHow the NHS could make money for Britain
The director of global health practice at KPMG outlines how the NHS could make money through innovation, highlighting UCL and UCL Hospital NHS Foundation Trust as a key place for such work to happen.
Read: The Times (£)
